Death receptors in cutaneous biology and disease

Journal of Investigative Dermatology

Volumn 115, Issue 2, 2000, Pages 141-148

  Wehrli, Philippe ^a   Viard, Isabelle ^a   Bullani, Roberto ^a   Tschopp, Jürg ^b   French, Lars E ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; Death receptors; Fas; Skin

Indexed keywords

GENE TRANSFER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN DISEASE; SKIN GRAFT;

EID: 0033883496     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00037.x     Document Type: Article

References (88)

1. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L
2. Gene transfer of Fas ligand induces tumor regression in vivo
3. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines
4. Death receptors: Signaling and modulation
5. Apoptosis control by death and decoy receptors
6. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice
7. Ras mutations in human melanoma: A marker of malignant progression
8. A role for CD95 ligand in preventing graft rejection
9. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense
10. Sunlight and sunburn in human skin cancer: P53, apoptosis, and tumor promotion
11. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
12. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
13. Epidermal tissue homeostasis
14. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas) -CD95 ligand-induced suicide
15. Human melanoma cells do not express Fas (Apo-1/CD95) ligand
16. Regulation of the proinflammatory effects of Fas ligand (CD95L)
17. Essential role for oncogenic Ras in tumour maintenance
18. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
19. The inhihitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
20. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)
21. Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10
22. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
23. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras
24. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
25. The TRAIL to selective tumor death
26. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes
27. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
28. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease
29. TRAIL: A molecule with multiple receptors and control mechanisms
30. Fas ligand-induced apoptosis as a mechanism of immune privilege
31. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
32. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express fas ligand
33. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
34. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies
35. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
36. A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation
37. Inhibition of death receptor signals by cellular FLIP
38. Analysis of ras mutations in human melanocytic lesions: Activation of the ras gene seems to be associated with the nodular type of human malignant melanoma
39. FasL interactions required for programmed cell death after T-cell activation
40. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
41. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
42. Fas/Fas ligand-mediated elimination of antigen-bearing Langerhans cells in draining lymph nodes
43. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells
44. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity
45. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand
46. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells
47. Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture
48. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
49. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes
50. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lyric pathways
51. Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes
52. Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells
53. Programmed cell death in terminally differentiating keratinocytes: Role of the endogenous endonuclease
54. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
55. Apoptosis in keratinocytes is not dependent on induction of differentiation
56. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease
57. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin
58. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy
59. Apoptosis by death factor
60. The Fas counterattack: Cancer as a site of immune privilege
61. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines
62. Fas and Fas ligand interactions suppress melanoma lung metastasis
63. 312-nanometer ultraviolet B light (narrowband UVB) induces apoptosis of T cells within psoriatic lesions
64. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
65. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
66. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
67. Does graft-versus-host disease attack epithelial stem cells
68. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes
69. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system
70. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
71. Apoptosis, Fas and Fas-ligand expression in melanocytic tumors
72. Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis
73. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
74. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
75. Inhibition of Fas death signals by FLIPs
76. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation
77. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma
78. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
79. Ras gene mutations: A rare event in nonmetastatic primary malignant melanoma
80. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
81. Caspase activation in the terminal differentiation of human epidermal keratinocytes
82. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
83. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
84. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: Selective rescue by caspase inhibition
85. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
86. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1
87. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
88. Sunburn and p53 in the onset of skin cancer